Chlamydia (cont.)

Sexually Transmitted Diseases (STDs) Slideshow Pictures

Medical Author:

Debra Houry, MD, MPH

Debra Houry, MD, MPH, is an Assistant Professor in the Department of Emergency Medicine at Emory University School of Medicine and in the Department of Behavioral Science and Health Education at the Rollins School of Public Health. She is currently the Director for the Center for Injury Control, Rollins School of Public Health and teaches several courses on violence and injury prevention at Emory.

View Full Profile

Medical Editor:

Melissa Conrad Stöppler, MD, Chief Medical Editor

Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.

View Full Profile

Chlamydia Prognosis

Treated with antibiotics, chlamydial infections can be cured 95% of the time.

Complications if not treated:

Ten percent to 40% of women will develop pelvic inflammatory disease;
5% of women with pelvic inflammatory disease will develop a form of liver disease (perihepatitis).

Women may develop chronic pelvic pain and become sterile due to blockage of the Fallopian tubes that allow the egg to be transported from the ovary to the women's womb.